Tachycardia-mediated cardiomyopathy: Recognition and management

[1]  S. Connolly,et al.  Effect of dronedarone on cardiovascular events in atrial fibrillation. , 2009, The New England journal of medicine.

[2]  Y. Yamahara,et al.  Myocardial stunning with partial aneurysmal formation generated during the recovering process of tachycardia-induced cardiomyopathy. , 2009, Journal of cardiology.

[3]  M. Endo,et al.  Improvement of cardiac function and neurological remodeling in a patient with tachycardia-induced cardiomyopathy after catheter ablation. , 2009, Journal of cardiology.

[4]  Jiunn-lee Lin,et al.  Radiofrequency catheter ablation of supraventricular tachycardia in infants and toddlers. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[5]  G. Cayla,et al.  A Case of Cardiomyopathy Induced by Inappropriate Sinus Tachycardia and Cured by Ivabradine , 2009, Pacing and clinical electrophysiology : PACE.

[6]  M. Haissaguerre,et al.  Tachycardia‐Induced Right Ventricular Cardiomyopathy: Epicardial Radiofrequency Ablation of an Unusual and Unexpected Ventricular Tachycardia , 2009, Journal of cardiovascular electrophysiology.

[7]  J. Kalman,et al.  Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation. , 2009, Journal of the American College of Cardiology.

[8]  W. Pikto-Pietkiewicz.  [The effect of dronedarone on the frequency of cardiovascular events in patients with atrial fibrillation - ATHENA studies]. , 2009, Kardiologia polska.

[9]  Jennifer G. Robinson,et al.  Resting heart rate as a low tech predictor of coronary events in women: prospective cohort study , 2009, BMJ : British Medical Journal.

[10]  B. Olshansky,et al.  Ibutilide revisited: stronger and safer than ever. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[11]  B. Olshansky,et al.  Slower heart rates for healthy hearts: time to redefine tachycardia? , 2008, Circulation. Arrhythmia and electrophysiology.

[12]  David O. Martin,et al.  Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. , 2008, The New England journal of medicine.

[13]  R. Naeije,et al.  Activin-A, transforming growth factor-beta, and myostatin signaling pathway in experimental dilated cardiomyopathy. , 2008, Journal of cardiac failure.

[14]  R. Ferrari,et al.  Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial , 2008, The Lancet.

[15]  John M. Miller,et al.  Persistent left ventricular dilatation in tachycardia-induced cardiomyopathy patients after appropriate treatment and normalization of ejection fraction. , 2008, Heart rhythm.

[16]  B. Gersh,et al.  Cardiomyopathy induced by pulmonary vein tachycardia cured by catheter ablation , 2008, Nature Clinical Practice Cardiovascular Medicine.

[17]  A. Camm,et al.  Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure , 2009 .

[18]  J. McMurray,et al.  Increased mortality after dronedarone therapy for severe heart failure. , 2008, The New England journal of medicine.

[19]  Jong-Min Song,et al.  Diagnostic Approach and Treatment Strategy in Tachycardia‐induced Cardiomyopathy , 2008, Clinical cardiology.

[20]  M. Nieminen,et al.  Abstract 2293: Incidence of Atrial Fibrillation in Relation to Changing Heart Rate Over Time in Hypertensive Patients: The LIFE Study , 2006 .

[21]  M. Kodama,et al.  Clinical characteristics, treatment, and outcome of tachycardia induced cardiomyopathy. , 2008, International heart journal.

[22]  Jean-Claude Tardif,et al.  Resting heart rate in cardiovascular disease. , 2007, Journal of the American College of Cardiology.

[23]  Frank Bogun,et al.  Radiofrequency ablation of frequent, idiopathic premature ventricular complexes: comparison with a control group without intervention. , 2007, Heart rhythm.

[24]  F. Gaita,et al.  Tachycardia-induced cardiomyopathy: mechanisms of heart failure and clinical implications , 2007, Journal of cardiovascular medicine.

[25]  H. Crijns,et al.  Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies. , 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[26]  I. V. Van Gelder,et al.  RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II. , 2006, American heart journal.

[27]  Xinxin Guo,et al.  Rapid electrical stimulation induces early activation of kinase signal transduction pathways and apoptosis in adult rat ventricular myocytes , 2006, Experimental physiology.

[28]  The effects of altering time delays of coupled pacing during acute atrial fibrillation. , 2006, Heart rhythm.

[29]  Ranjan Thakur,et al.  Tachycardia‐Induced Cardiomyopathy: A Review of Literature , 2005, Pacing and clinical electrophysiology : PACE.

[30]  Peter J. Schwartz,et al.  Heart-rate profile during exercise as a predictor of sudden death. , 2005, The New England journal of medicine.

[31]  Prashanthan Sanders,et al.  Catheter ablation for atrial fibrillation in congestive heart failure. , 2004, The New England journal of medicine.

[32]  B. Olshansky,et al.  Heart Failure and Sudden Death in Patients With Tachycardia-Induced Cardiomyopathy and Recurrent Tachycardia , 2004, Circulation.

[33]  Brian Olshansky,et al.  The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation. , 2004, Journal of the American College of Cardiology.

[34]  S. Julius,et al.  Elevated Heart Rate: A Major Risk Factor for Cardiovascular Disease , 2004, Clinical and experimental hypertension.

[35]  J. Noti,et al.  Association of angiotensin converting enzyme gene polymorphism with tachycardia cardiomyopathy. , 2002, International journal of molecular medicine.

[36]  B. Olshansky,et al.  Outpatient cardioversion of atrial arrhythmias: efficacy, safety, and costs. , 2003, American heart journal.

[37]  C. Solares,et al.  Tachycardia-induced cardiomyopathy. , 2003, The American journal of medicine.

[38]  Paul Dagum,et al.  Alterations in left ventricular torsion in tachycardia-induced dilated cardiomyopathy. , 2002, The Journal of thoracic and cardiovascular surgery.

[39]  F. Wittkampf,et al.  Rapid Recovery of Cardiac Function after Catheter Ablation of Persistent Junctional Reciprocating Tachycardia in Children , 2002, Pacing and clinical electrophysiology : PACE.

[40]  U. Heidland,et al.  Left Ventricular Muscle Mass and Elevated Heart Rate Are Associated With Coronary Plaque Disruption , 2001, Circulation.

[41]  S. Connolly,et al.  Amiodarone to Prevent Recurrence of Atrial Fibrillation , 2000 .

[42]  Bramahn . Singh,et al.  Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. , 1999, Journal of the American College of Cardiology.

[43]  P C Deedwania,et al.  Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators. , 1998, Circulation.

[44]  Z. Blanck,et al.  Atrioventricular nodal modification and atrioventricular junctional ablation for control of ventricular rate in atrial fibrillation. , 1998, Journal of cardiovascular electrophysiology.

[45]  J. Luchsinger,et al.  Resolution of cardiomyopathy after ablation of atrial flutter. , 1998, Journal of the American College of Cardiology.

[46]  A. Takeshita,et al.  Role of microtubules in the contractile dysfunction of myocytes from tachycardia-induced dilated cardiomyopathy. , 1998, Journal of molecular and cellular cardiology.

[47]  Z. Galis,et al.  Myocardial matrix metalloproteinase activity and abundance with congestive heart failure. , 1998, American journal of physiology. Heart and circulatory physiology.

[48]  M. Josephson,et al.  Incessant Fascicular Tachycardia: A Cause of Arrhythmia Induced Cardiomyopathy , 1998, Pacing and clinical electrophysiology : PACE.

[49]  D. Kass,et al.  Repolarization abnormalities, arrhythmia and sudden death in canine tachycardia-induced cardiomyopathy. , 1997, Journal of the American College of Cardiology.

[50]  M. Eronen.  Outcome of fetuses with heart disease diagnosed in utero , 1997, Archives of disease in childhood. Fetal and neonatal edition.

[51]  K. Ellenbogen,et al.  Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. , 1997, Journal of the American College of Cardiology.

[52]  P. Rakovec,et al.  Tachycardia induced cardiomyopathy in dogs; relation between chronic supraventricular and chronic ventricular tachycardia. , 1996, International journal of cardiology.

[53]  U. Kaul,et al.  Reversibility of “Tachycardia Induced Cardiomyopathy” Following the Cure of Idiopathic Left Ventricular Tachycardia Using Radiofrequency Energy , 1996, Pacing and clinical electrophysiology : PACE.

[54]  F. Spinale,et al.  Cellular and extracellular remodeling with the development and recovery from tachycardia-induced cardiomyopathy: changes in fibrillar collagen, myocyte adhesion capacity and proteoglycans. , 1996, Journal of molecular and cellular cardiology.

[55]  P. Anversa,et al.  The cellular basis of pacing-induced dilated cardiomyopathy. Myocyte cell loss and myocyte cellular reactive hypertrophy. , 1995, Circulation.

[56]  P. Armstrong,et al.  How does intermittent pacing modify the response to rapid ventricular pacing in experimental heart failure? , 1995, Journal of cardiac failure.

[57]  Afonso Mr,et al.  Sudden death and tachycardiomyopathy in a young man with incessant tachycardia , 1992 .

[58]  F. Spinale,et al.  Alterations in myocyte shape and basement membrane attachment with tachycardia-induced heart failure. , 1991, Circulation research.

[59]  W G Stevenson,et al.  Prognostic Significance of Atrial Fibrillation in Advanced Heart Failure: A Study of 390 Patients , 1991, Circulation.

[60]  A. Smith,et al.  Chronic supraventricular tachycardia causes ventricular dysfunction and subendocardial injury in swine. , 1990, The American journal of physiology.

[61]  J. Gallagher.  Tachycardia and cardiomyopathy: the chicken-egg dilemma revisited. , 1985, Journal of the American College of Cardiology.

[62]  Silvia G. Priori,et al.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC , 2006 .